Access pathways have expanded
Over the past several years, incretin-based peptide research has expanded significantly due to promising findings in metabolic signaling studies
Additional sensitivity analysis compared new GLP-1 RAs users with individuals commencing other second-line antihyperglycemic treatments, including Sulfonylureas, dipeptidyl peptidase-4 inhibitors, or Pioglitazone
Label status: In January 2025, the Ozempic label was updated to state that it is not recommended in patients with severe gastroparesis, but does not indicate that the drug itself may cause the condition
Full List of Services: + Diamond Glow (Advanced) Facial + Ultimate Massage + Full Body Scrub & Polish + Shea Butter Pedicure + Manicure + Deep Conditioning Hair Treatment + Blowdry/Style + Gourmet Spa Lunch w/ Wine Deluxe Getaway for Two $740.00 / ~4.5 hours Couples Spa Day
Cardiovascular Diabetology, 8(1), 12